| |
| |
|
| Insider
Information: |
Bradbury Daniel |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
232,105 |
|
|
Indirect Shares
|
3,161,475 |
|
|
| Direct
Value |
$2,471,016 |
|
|
|
Indirect Value
|
$4,283,565 |
|
|
| Total
Shares |
3,393,580 |
|
|
| Total
Value |
$6,754,581 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amylin Pharmaceuticals Inc |
AMLN |
President & Chief Exec... |
2012-08-08 |
0 |
2012-08-08 |
0 |
Premium* |
|
|
Paratek Pharmaceuticals Inc |
PRTK |
Director |
2006-05-09 |
35,714 |
|
0 |
Premium* |
|
|
Illumina Inc |
ILMN |
Director |
2017-05-25 |
15,324 |
2008-05-16 |
0 |
Premium* |
|
|
Corcept Therapeutics Inc |
CORT |
Director |
2012-11-21 |
0 |
2019-02-07 |
130,575 |
Premium* |
|
|
Geron Corporation |
GERN |
Director |
2014-05-09 |
142,776 |
2019-03-29 |
51,323 |
Premium* |
|
|
Equillium Inc |
EQ |
Chief Executive Office... |
2018-10-16 |
0 |
2018-10-16 |
2,969,596 |
Premium* |
|
|
Castle Biosciences Inc |
CSTL |
Director |
2024-05-25 |
13,291 |
2024-05-06 |
9,981 |
Premium* |
|
|
Nuvation Bio Ord Shs Class A |
NUVB |
Director |
2021-02-10 |
25,000 |
2021-02-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
424 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 15 of 17
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2015-06-23 |
4 |
S |
$6.92 |
$69,200 |
I/I |
(10,000) |
307,925 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2015-06-24 |
4 |
S |
$6.57 |
$65,700 |
I/I |
(10,000) |
297,925 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2015-07-20 |
4 |
S |
$5.32 |
$53,200 |
I/I |
(10,000) |
287,925 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2015-07-21 |
4 |
S |
$4.98 |
$49,800 |
I/I |
(10,000) |
277,925 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2015-08-26 |
4 |
S |
$4.54 |
$45,351 |
I/I |
(10,000) |
267,925 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2015-08-27 |
4 |
S |
$4.99 |
$49,900 |
I/I |
(10,000) |
257,925 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2015-09-15 |
4 |
S |
$5.00 |
$50,045 |
I/I |
(10,000) |
247,925 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2015-09-16 |
4 |
S |
$4.91 |
$49,079 |
I/I |
(10,000) |
237,925 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2015-11-24 |
4 |
S |
$5.10 |
$51,024 |
I/I |
(10,000) |
197,925 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2015-12-09 |
4 |
S |
$4.81 |
$48,122 |
I/I |
(10,000) |
187,925 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2015-12-10 |
4 |
S |
$4.88 |
$48,814 |
I/I |
(10,000) |
177,925 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2017-03-10 |
4 |
GD |
$0.00 |
$0 |
I/I |
10,000 |
155,575 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-04-03 |
4 |
AS |
$22.14 |
$227,991 |
I/I |
(10,300) |
85,745 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2020-05-20 |
4 |
AS |
$36.84 |
$415,140 |
I/I |
(11,250) |
897,328 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-03-02 |
4 |
AS |
$23.16 |
$264,411 |
I/I |
(11,349) |
90,535 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2024-02-05 |
4 |
AS |
$22.74 |
$261,134 |
I/I |
(11,402) |
37,954 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2020-10-20 |
4 |
AS |
$49.63 |
$583,948 |
I/I |
(11,750) |
791,828 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2024-04-05 |
4 |
AS |
$20.86 |
$245,543 |
I/I |
(11,771) |
18,768 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2021-01-12 |
4 |
AS |
$77.32 |
$948,366 |
I/I |
(12,113) |
403,493 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-11-30 |
4 |
AS |
$20.08 |
$244,566 |
I/I |
(12,179) |
57,786 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2016-11-07 |
4 |
GD |
$0.00 |
$0 |
I/I |
12,350 |
165,575 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
• – – |
2006-02-16 |
4 |
OE |
$0.78 |
$9,802 |
D/D |
12,551 |
39,151 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
• – – |
2006-02-16 |
4 |
AS |
$38.25 |
$480,076 |
D/D |
(12,551) |
26,600 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
• – – |
2006-02-21 |
4 |
OE |
$0.78 |
$9,802 |
D/D |
12,551 |
39,151 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
• – – |
2006-02-21 |
4 |
AS |
$39.65 |
$497,647 |
D/D |
(12,551) |
26,600 |
|
- |
|
424 Records found
|
|
Page 15 of 17 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
